Cosmo Pharmaceuticals is a specialty pharmaceutical company that develops and manufactures prescription medicines, mainly for gastrointestinal conditions. Its products include treatments for inflammatory bowel disease and preparations used to cleanse the bowel before diagnostic examinations of the colon. The company also provides contract manufacturing of finished medicines for other pharmaceutical firms. It is based in Ireland, with operations and production facilities in Europe, and it supplies healthcare markets internationally through partners and its own commercial activities.
COSMO Pharmaceuticals SA trades under the code 0RGI on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3493 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
7/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-31.1%
From 52-week high-57.3%
MomentumWeak
14/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-21.4%
6-month return-42.4%
12-month, skipping last month-15.6%
Stability (higher is calmer)Weak
23/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)44.5%
Worst drawdown, 1 year (smaller is calmer)-60.7%
LiquidityWeak
36/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.18M GBP
Zero-volume days0.0%
IncomeNone
–/100
Dividends were paid, but the vendor data does not give a reliable yield for this listing.
See the numbers →
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 49.20 – 129.60Daily closes, split-adjusted
Signals
50-day average54.69
200-day average77.67
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)1.67
Technical summary
Daily
Neutral
5 bullish · 4 neutral · 7 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
51.74
Bullish
EMA 10
52.41
Bullish
SMA 20
52.43
Bullish
EMA 20
52.77
Bullish
SMA 50
54.69
Bearish
EMA 50
55.31
Bearish
SMA 100
59.85
Bearish
EMA 100
60.84
Bearish
SMA 200
77.67
Bearish
EMA 200
67.65
Bearish
Oscillators (daily)
RSI (14)
51.09
Neutral
MACD (12, 26)
-0.75
Bearish
Momentum (12)
2.69
Bullish
Stochastic %K (14)
75.44
Neutral
Williams %R (14)
-24.56
Neutral
CCI (20)
24.51
Neutral
Pivot points (classic, last session)
S3
51.50
S2
51.90
S1
52.70
Pivot
53.10
R1
53.90
R2
54.30
R3
55.10
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.02 GBX
Yield on today's price
–
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.0193
0.0192
0.0195
0.0102
0.0098
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in GBP. Educational only, not financial advice.
